Khadim India Ltd

Khadim India Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were recommended by the Audit Committee. The financial statements, along with the limited review report from statutory auditors Ray & Ray, have been submitted and will be available on the company's website. The review confirmed no material misstatements in the standalone financial statement.

Khadim India's consolidated revenue came in at ₹77.84 Cr for Q1 FY27, down 18.7% year-on-year from ₹95.70 Cr and down 6.8% sequentially from ₹83.56 Cr. Consolidated PAT fell more sharply — ₹0.52 Cr, down 38.7% YoY from ₹0.85 Cr and down 30.7% QoQ from ₹0.75 Cr. Standalone figures track almost identically (PAT ₹0.52 Cr, EPS ₹0.29) since the Bangladesh subsidiary is financially immaterial. Neither the current quarter nor either comparison quarter carries an exceptional item, so this is a clean like-for-like decline, not a base-effect artefact. The profit decline outpaced the revenue decline because margins compressed on both counts: OPM fell to roughly 10.1% from 14.2% in the preceding quarter and 12.9% a year ago, while NPM slipped to 0.62% from 0.87% in both comparison quarters. Combined material and stock-in-trade costs (₹530.3 mn) and broadly flat employee costs (₹113.6 mn) did not scale down with the softer topline, squeezing operating leverage — typical for footwear retail in the seasonally quiet June quarter ahead of the festive H2 ramp. Management's FY27 guidance from the Q4FY26 call called for full-year revenue to stabilize near ₹400 Cr with a 14% EBITDA margin and 2-2.5% PAT margins. Annualising Q1's ₹77.84 Cr run-rate implies roughly ₹311 Cr for the year, and the 0.62% PAT margin is well short of the guided band — the quarter is tracking behind that outlook, though Q1 is seasonally the softest for footwear and one quarter doesn't settle the full-year path. No analyst estimates for this small-cap turned up in search, so the print cannot be benchmarked against street consensus. Alongside the results, the company's August 1 EGM approved issuing 10,22,727 fully convertible equity warrants at ₹110/share (₹100 premium to the ₹10 face value) to promoter and non-promoter allottees, aggregating up to ₹11.25 Cr, with in-principle stock-exchange approval still pending as of the results date. That capital raise sits alongside the margin story as the two threads to track into the festive quarters.

Khadim India Ltd has received in-principle approval for the issuance of 10,22,727 Fully Convertible Equity Share Warrants at ₹10 each on a preferential basis. This approval follows a special resolution passed by shareholders at an Extra-ordinary General Meeting (EGM) held on August 01, 2026. The company confirmed that the issue price will be re-computed as per SEBI's ICDR Regulations if required, with warrants remaining locked-in until any re-computed amount is paid.

Khadim India Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter, which ended on June 30, 2026. This announcement is made in compliance with SEBI's Listing Regulations.

Khadim India Limited held an Extra-Ordinary General Meeting (EGM) on August 01, 2026, to vote on key resolutions. The primary agenda item was the issuance of up to 10,22,727 Fully Convertible Equity Share Warrants on a preferential basis to promoter and non-promoter categories. The meeting also included the appointment of Mr. Sekhar Bhattacharjee as an independent director. Voting results indicate overwhelming support for both resolutions, with a significant majority of votes cast in favour. The EGM was conducted via two-way Video Conferencing.

Khadim India Ltd has issued a corrigendum to its Extra-ordinary General Meeting (EGM) notice, originally scheduled for August 01, 2026. The corrigendum revises details related to the preferential issue of Fully Convertible Equity Share Warrants. The issue size has been reduced to 10,22,727 warrants at ₹110 each, aggregating up to ₹11.25 crore. This revision is due to changes in the list of proposed allottees, with Ms. Palak Sanjay Agarwal being removed. The company is also amending utilization of issue proceeds and shareholding pattern estimates. The EGM will still be held via Video Conferencing / Other Audio Visual Means.

Khadim India Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on August 01, 2026, at 11:30 a.m. IST via Video Conferencing. The primary agenda is to consider and approve the issuance of up to 10,68,182 Fully Convertible Equity Share Warrants on a preferential basis to promoter and non-promoter categories. The warrants will be issued at an exercise price of ₹110 per share, convertible into equity shares of face value ₹10 each. The total issue size is aggregated up to ₹11.75 crore. The company is also providing e-voting facilities for shareholders.

Khadim India Ltd announced on July 02, 2026, that its Board of Directors has approved an alteration to the company's Articles of Association. The modification specifically pertains to the clause that determines the pricing for future capital issuances. This change is subject to the approval of the company's shareholders. The update was made in accordance with Regulation 30 of the Listing Regulations and a SEBI Circular.

Khadim India Ltd has issued a corrigendum to the outcome of its Board Meeting held on July 02, 2026. The company corrected typographical errors in 'Annexure A' regarding the 'Maximum Number of Warrants Offered' to proposed allottees. The total number of warrants offered remains 10,68,182, distributed among promoters and non-promoter/public individuals and entities. The rest of the earlier communication remains unchanged.

Khadim India Ltd's Board of Directors approved the issuance of up to 10,68,182 Fully Convertible Equity Share Warrants at ₹110 each to promoters and identified non-promoters, aggregating ₹11.75 crore. The warrants are convertible into equity shares within 18 months. Additionally, the board approved the continuation of Prof. (Dr.) Surabhi Banerjee as an Independent Director post-75 years and the appointment of Mr. Sekhar Bhattacharjee as an Additional Independent Director. An Extraordinary General Meeting (EGM) will be convened on August 01, 2026, to seek shareholder approval for these proposals, including a change in the Articles of Association.